The Original Triad: Disordered Eating, Amenorrhea, and Bone Loss
When the American College of Sports Medicine published its first position statement on the female athlete triad in 1992, it described what clinicians in sports medicine had been observing for years: a cluster of three interrelated health problems appearing together in female athletes at disproportionate rates. Disordered eating — spanning from clinical anorexia and bulimia through subclinical restriction — was the primary driver. Menstrual dysfunction — loss of periods (amenorrhea) or severely reduced cycle frequency (oligomenorrhea) — was the most visible physiological consequence. And low bone density — the silent accumulation of structural compromise that appeared only on DEXA scans or, catastrophically, as a stress fracture — was the most medically serious long-term outcome.
The sports at highest prevalence were those with aesthetic or weight-class components: gymnastics, figure skating, ballet, rowing lightweight division, distance running, and cycling. Elite female gymnasts were the original index population. But the 1992 framework had a limitation that took more than two decades to fully address: it framed the triad primarily as an eating disorder problem in a specific population of female athletes. This framing missed a large and clinically important group.
Low Energy Availability: The Unifying Mechanism
The conceptual breakthrough that expanded the triad into the broader RED-S framework was the identification of energy availability (EA) as the fundamental causal variable. Energy availability is defined as dietary energy intake minus the energy cost of exercise training, expressed per kilogram of fat-free mass (FFM):
EA = (Energy intake kcal − Exercise energy expenditure kcal) ÷ kg FFM
The threshold below which physiological consequences emerge is approximately 30 kcal/kg FFM/day, established through controlled studies by Anne Loucks and colleagues at Ohio University in the 1990s and 2000s. Below 30 kcal/kg FFM/day, LH pulsatility suppresses within days, reproductive hormones fall, and the body begins conserving energy through reduced metabolic rate, thyroid function suppression, and growth hormone resistance. Above 45 kcal/kg FFM/day — the threshold considered optimal for health — reproductive, bone, and metabolic function are well maintained.
This energy availability framework transformed the clinical understanding of the triad. It meant that an athlete with no eating disorder — who was simply eating a volume of food that would be appropriate for a sedentary or moderately active person but was grossly inadequate for her actual training load — could develop the full clinical picture of the triad through purely inadvertent underfueling.
The 2014 IOC Consensus: RED-S Expands the Framework
The International Olympic Committee Medical Commission's 2014 consensus statement (Mountjoy et al., British Journal of Sports Medicine) introduced the term Relative Energy Deficiency in Sport (RED-S) to encompass the full breadth of low-EA consequences. The IOC statement made two landmark expansions.
Expansion 1: Eleven affected systems. The IOC consensus catalogued health consequences of LEA spanning: metabolic rate suppression (reduced basal metabolic rate as an energy conservation response), menstrual dysfunction (in females) and testosterone suppression (in males), bone health deterioration (impaired formation, increased resorption), immune impairment (increased susceptibility to upper respiratory infections and delayed healing), protein synthesis reduction (impaired muscle repair and adaptation), cardiovascular health effects (including bradycardia and cardiac remodelling in severe cases), psychological consequences (depression, anxiety, cognitive impairment), gastrointestinal dysfunction (reduced gut motility), hematological effects (reduced iron absorption and erythropoiesis), impaired growth and development (in adolescent athletes), and — critically — impaired athletic performance itself (reduced strength, power, endurance, and training adaptability).
Expansion 2: Male athletes included. The IOC consensus explicitly acknowledged that male athletes develop RED-S consequences through the same low-EA mechanism, experiencing testosterone suppression, bone density loss, immune suppression, and performance impairment — without the menstrual dysfunction that had previously served as the diagnostic anchor for the triad.
The Kisspeptin-GnRH Pathway: How Underfueling Silences Reproduction
The neuroendocrine mechanism by which low energy availability suppresses menstrual function has been substantially clarified over the past 15 years. The central mediator is kisspeptin — a neuropeptide produced by neurons in the arcuate nucleus of the hypothalamus that acts as a metabolic sensor and master regulator of reproductive axis activity.
Kisspeptin neurons integrate signals from multiple metabolic hormones including leptin, insulin, and neuropeptide Y. When energy availability falls, leptin drops (leptin is secreted by adipose tissue in proportion to fat mass and caloric intake), insulin falls with caloric restriction, and the metabolic hormonal milieu suppresses kisspeptin secretion. Reduced kisspeptin means reduced GnRH pulsatility from the hypothalamus; reduced GnRH means reduced LH and FSH from the pituitary; reduced LH means the ovaries stop cycling. The result is functional hypothalamic amenorrhea (FHA): a fully reversible suppression of reproductive function driven by metabolic signals, not by structural damage to the ovaries or pituitary.
Anne Loucks's controlled studies demonstrated changes in LH pulsatility within 3–5 days of imposing severe energy restriction in exercising women — faster than almost any clinician or athlete would expect. The bone consequences accumulate more slowly over months of amenorrhea but are compounded by the fact that the bone-protecting effects of estrogen are absent during this period.
Bone Consequences: Stress Fractures and Irreversible Loss
Bone is not static — it is continuously remodelled by osteoclasts (resorption) and osteoblasts (formation), with the balance maintained by estrogen, mechanical loading, and adequate caloric and nutritional status. In the context of LEA and amenorrhea, bone remodelling shifts toward net resorption: osteoclast activity is relatively preserved while osteoblast function is suppressed by low IGF-1, low estrogen, and elevated cortisol.
The clinical consequences are significant. Female athletes with functional hypothalamic amenorrhea have stress fracture rates 2–4 times higher than eumenorrheic athletes matched for training load. The lumbar spine — which depends heavily on estrogen for maintenance — is the skeletal site most severely affected by amenorrhea-related bone loss, which is clinically important because spinal bone loss in young women may be permanent even after hormonal recovery.
A prospective study by Drinkwater and colleagues showed that bone density in amenorrheic athletes who resumed menstruation with recovery did not fully normalize to the expected level for their age even after 2 years — particularly at the spine. This represents a deficit that is carried into older age, shifting the baseline from which menopausal bone loss begins and increasing lifetime fracture risk.
The stress fracture pattern in RED-S — particularly trabecular bone sites like the femoral neck and sacrum rather than the cortical bone of the tibia and fibula that typify biomechanical stress fractures — should prompt metabolic and hormonal evaluation in any athlete presenting with recurrent or atypical stress fractures, even in the absence of overt menstrual dysfunction or eating disorder history.
Case Illustration: The Elite Runner
A 24-year-old competitive 10,000m runner presents with a fourth stress fracture in two years — this time the femoral neck — following previous stress fractures of the sacrum, tibial shaft, and metatarsal. She reports her periods stopped 18 months ago. She eats "very clean" — no processed foods, limited dairy, approximately 2,100 kcal/day — and trains 90 miles per week. She attributes her amenorrhea to her training load and has been told by coaches that "serious runners don't get their period."
DEXA scan reveals lumbar spine Z-score of −2.1 (well below expected for her age). Serum estradiol is 12 pg/mL (prepubertal range). LH is 0.8 mIU/mL. Her REE is measured by indirect calorimetry at 1,400 kcal/day — nearly 20% below predicted for her body weight, consistent with metabolic rate suppression from chronic LEA. Her energy availability is calculated at approximately 18–22 kcal/kg FFM/day — well below the 30 kcal/kg FFM/day threshold.
This case is not unusual. The normalization of amenorrhea in elite female distance runners — sometimes described as a marker of serious training — is one of the most clinically damaging misconceptions in sports medicine. Amenorrhea at any age is not normal and represents a medical condition requiring evaluation and treatment.
Screening, Assessment, and the RED-S CAT
The Low Energy Availability in Females Questionnaire (LEAF-Q) is a validated 25-item screening tool that identifies female athletes at risk of LEA based on reported injury history, gastrointestinal symptoms, and menstrual history. A score of 8 or higher indicates high risk. The RED-S Clinical Assessment Tool (RED-S CAT) published in the 2014 IOC consensus provides a traffic-light risk stratification system (red: not cleared for competition; yellow: cleared with restrictions and monitoring; green: cleared) based on the severity of LEA consequences across multiple systems.
Key screening questions for all female athletes should include: Are your periods regular? When did you last have a period? Have you ever had a stress fracture? Do you track your diet? Are there foods or food groups you avoid? Do you feel like you have enough energy for your training? The presence of amenorrhea, stress fracture history, or significant dietary restriction should prompt full metabolic and hormonal evaluation.
Recovery: Caloric Repletion, Multidisciplinary Care, and Return to Sport
The core treatment is increasing energy availability — a target of 45 kcal/kg FFM/day or above, sustained consistently. For athletes who have been chronically underfueling, the adjustment is psychologically and practically challenging: reaching this target may require doubling caloric intake, which conflicts with weight-control goals, sport culture pressure, and often with deeply held beliefs about appropriate eating.
A registered sports dietitian experienced in RED-S is essential — general nutrition advice is not adequate, and a caloric target must be individualized to the athlete's specific training load and body composition. Where disordered eating or clinical eating disorders are present, a psychologist or eating disorder specialist should be integral to the team, using cognitive behavioral therapy (CBT) or dialectical behavior therapy (DBT) as evidence-based interventions. The sports medicine physician monitors hormonal recovery, bone health follow-up, and return-to-sport decisions.
Combined oral contraceptives are explicitly not recommended for managing RED-S-related amenorrhea. They produce withdrawal bleeding that mimics menstruation but does not reflect HPG axis recovery, suppress endogenous LH and FSH further, and have not been shown to improve bone density in LEA-related amenorrhea — and may impair it. The only treatment that restores menstrual function and improves bone health in RED-S is restoring energy availability.
Return-to-sport criteria include: documented caloric intake meeting targets for at least 3–4 weeks, two or three consecutive spontaneous menstrual cycles (not withdrawal bleeds from hormonal contraceptives), and radiological evidence of healing for any stress fracture. Athletes should be counselled that the performance gains from adequate fueling — improved recovery, training adaptations, immune function, and reduced injury rate — substantially outweigh the weight changes that may accompany caloric normalization.